Treatments & Interventions
Estrone
substance
Estrogen receptor agonist-containing product
product
Estradiol benzoate
substance
Estradiol valerate
substance
Estradiol cypionate
substance
Estradiol hemihydrate
substance
Polyestradiol phosphate
substance
Ethinylestradiol
substance
Conjugated estrogen
substance
Esterified estrogen
substance
Estradiol
substance
Sodium estrone sulfate
substance
Clonidine
substance
Clonidine hydrochloride
substance
Piperazine estrone sulfate
substance
Tibolone
substance
Quinestrol
substance
Cimicifuga racemosa extract
substance
Cimicifuga racemosa preparation
product
Estradiol acetate
substance
Clinical Trials
Recent Trials
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
Guided Digital Self-Hypnosis Solution for Managing Hot Flashes in Patients Undergoing Adjuvant Hormone Therapy
The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health.
A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
A Study to Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through Menopause
Research Evidence
Peer-reviewed studies linked via MeSH term "Flashes, Hot" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Related Conditions
Quick Facts
- SNOMED CT
- 198436008
- UMLS CUI
- C0600142
- Fully Specified Name
- Menopausal flushing (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Known Treatments
- 20
- Clinical Trials
- 20
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.